{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=11700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=11100","results":[{"registry_id":"NCT03118518","publication_url":"https://clinicaltrials.gov/study/NCT03118518","title":"STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation","has_exemption":false,"start_date":"2017-06-23","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03264066","publication_url":"https://clinicaltrials.gov/study/NCT03264066","title":"A Phase II, Open-Label, Multicenter, Multicohort Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Patients With Solid Tumors","has_exemption":true,"start_date":"2017-11-23","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03428360","publication_url":"https://clinicaltrials.gov/study/NCT03428360","title":"An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy","has_exemption":false,"start_date":"2018-01-23","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Aquestive Therapeutics","sponsor_slug":"aquestive-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03297216","publication_url":"https://clinicaltrials.gov/study/NCT03297216","title":"Z 31702 - Improving Pregnancy Outcomes With Progesterone (IPOP): a Trial of 17-Hydroxyprogesterone Caproate to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy","has_exemption":false,"start_date":"2018-02-07","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03235414","publication_url":"https://clinicaltrials.gov/study/NCT03235414","title":"Determination of Normal Liver Stiffness by MR Elastography in Children","has_exemption":false,"start_date":"2018-02-19","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03605745","publication_url":"https://clinicaltrials.gov/study/NCT03605745","title":"Minimally Invasive Prostatic Vapor Ablation - Multicenter, Single Arm Study for the Treatment of BPH in Large Prostates (Rezūm XL)","has_exemption":false,"start_date":"2018-06-19","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03697460","publication_url":"https://clinicaltrials.gov/study/NCT03697460","title":"INCB018424 in the Treatment of Cutaneous Lichen Planus","has_exemption":false,"start_date":"2018-08-30","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Aaron R. Mangold","sponsor_slug":"aaron-r-mangold","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03772587","publication_url":"https://clinicaltrials.gov/study/NCT03772587","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2019-04-10","completion_date":"2020-06-25","has_results":true,"results_due":true,"sponsor_name":"Momenta Pharmaceuticals, Inc.","sponsor_slug":"momenta-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04085055","publication_url":"https://clinicaltrials.gov/study/NCT04085055","title":"Randomized Trial Comparing Fine Needle Biopsy Needles and Different Techniques for Endoscopic-guided Fine Needle Biopsy of Solid Pancreatic Mass Lesions","has_exemption":false,"start_date":"2019-09-09","completion_date":"2020-06-25","has_results":false,"results_due":true,"sponsor_name":"AdventHealth","sponsor_slug":"adventhealth","status":"overdue","is_pact":false,"days_late":1770},{"registry_id":"NCT02053363","publication_url":"https://clinicaltrials.gov/study/NCT02053363","title":"Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial","has_exemption":false,"start_date":"2014-03-31","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported-late","is_pact":true,"days_late":156},{"registry_id":"NCT02337829","publication_url":"https://clinicaltrials.gov/study/NCT02337829","title":"A Phase II Study Using ACP-196 (Acalabrutinib) in Patients With Relapsed/Refractory and Treatment-naïve Deletion 17p CLL/SLL: Pharmacodynamic Assessment of BTK Inhibition and Antitumor Response.","has_exemption":false,"start_date":"2015-01-12","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02586857","publication_url":"https://clinicaltrials.gov/study/NCT02586857","title":"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)","has_exemption":false,"start_date":"2016-01-25","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03057613","publication_url":"https://clinicaltrials.gov/study/NCT03057613","title":"A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck","has_exemption":false,"start_date":"2017-05-10","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03423823","publication_url":"https://clinicaltrials.gov/study/NCT03423823","title":"An Active-treatment Study of the Efficacy of Ziv-aflibercept in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2017-07-07","completion_date":"2020-06-26","has_results":false,"results_due":true,"sponsor_name":"Kapil Kapoor","sponsor_slug":"kapil-kapoor","status":"overdue","is_pact":false,"days_late":1769},{"registry_id":"NCT03059914","publication_url":"https://clinicaltrials.gov/study/NCT03059914","title":"A Histomorphometric Analysis of New Bone Formation Following Sinus Augmentation Using Two Different Bone Graft Materials. A Pilot Study in Humans.","has_exemption":false,"start_date":"2017-08-10","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"reported-late","is_pact":false,"days_late":584},{"registry_id":"NCT04405089","publication_url":"https://clinicaltrials.gov/study/NCT04405089","title":"Role of Transcranial Direct Current Stimulation to Decrease Impulsivity and Compulsivity in Individuals With Obesity","has_exemption":false,"start_date":"2018-05-03","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Minneapolis Veterans Affairs Medical Center","sponsor_slug":"minneapolis-veterans-affairs-medical-center","status":"reported-late","is_pact":false,"days_late":672},{"registry_id":"NCT03926117","publication_url":"https://clinicaltrials.gov/study/NCT03926117","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition","has_exemption":true,"start_date":"2019-06-03","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04006145","publication_url":"https://clinicaltrials.gov/study/NCT04006145","title":"A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study to Explore the Efficacy and Safety of Elobixibat in Adults With Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)","has_exemption":false,"start_date":"2019-06-06","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"Albireo","sponsor_slug":"albireo","status":"reported-late","is_pact":false,"days_late":39},{"registry_id":"NCT04118270","publication_url":"https://clinicaltrials.gov/study/NCT04118270","title":"Shared Decision-Making: Implementing the AFib 2getherTM Mobile App","has_exemption":false,"start_date":"2019-11-01","completion_date":"2020-06-26","has_results":true,"results_due":true,"sponsor_name":"University of Massachusetts, Worcester","sponsor_slug":"university-of-massachusetts-worcester","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03938038","publication_url":"https://clinicaltrials.gov/study/NCT03938038","title":"Guidance of Ultrasound in Intensive Care to Direct Euvolemia: A Cluster Randomized Crossover Comparative Effectiveness Trial (GUIDE Trial)","has_exemption":true,"start_date":"2019-09-06","completion_date":"2020-06-27","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04258423","publication_url":"https://clinicaltrials.gov/study/NCT04258423","title":"Preservation of Renal Function After Liver Transplant for Patients With Pre-existing Chronic Kidney Disease or Peri-operative Acute Kidney Injury Using Everolimus Plus Mycophenolate Mofetil Immunosuppression Regimen","has_exemption":false,"start_date":"2019-12-19","completion_date":"2020-06-27","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":51},{"registry_id":"NCT03506113","publication_url":"https://clinicaltrials.gov/study/NCT03506113","title":"GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial","has_exemption":false,"start_date":"2018-04-01","completion_date":"2020-06-28","has_results":false,"results_due":true,"sponsor_name":"Osaka General Medical Center","sponsor_slug":"osaka-general-medical-center","status":"overdue","is_pact":false,"days_late":1767},{"registry_id":"NCT00116142","publication_url":"https://clinicaltrials.gov/study/NCT00116142","title":"Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial","has_exemption":false,"start_date":"2005-06-30","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02217709","publication_url":"https://clinicaltrials.gov/study/NCT02217709","title":"Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer","has_exemption":false,"start_date":"2014-09-08","completion_date":"2020-06-29","has_results":false,"results_due":true,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"reported-late","is_pact":true,"days_late":1557},{"registry_id":"NCT02227667","publication_url":"https://clinicaltrials.gov/study/NCT02227667","title":"Phase II Study to Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer","has_exemption":false,"start_date":"2014-12-02","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03188991","publication_url":"https://clinicaltrials.gov/study/NCT03188991","title":"A Trial Evaluating Escalating Doses and the Safety of Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms","has_exemption":false,"start_date":"2017-09-29","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"NanOlogy, LLC","sponsor_slug":"nanology-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03331562","publication_url":"https://clinicaltrials.gov/study/NCT03331562","title":"A SU2C Catalyst ® Randomized Phase II Trial of the PD1 Inhibitor Pembrolizumab With or Without a Vitamin D Receptor Agonist Paricalcitol in Patients With Stage IV Pancreatic Cancer Who Have Been Placed in Best Possible Response","has_exemption":false,"start_date":"2017-12-27","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Translational Genomics Research Institute","sponsor_slug":"translational-genomics-research-institute","status":"reported-late","is_pact":false,"days_late":133},{"registry_id":"NCT03693170","publication_url":"https://clinicaltrials.gov/study/NCT03693170","title":"Phase II, Open-label, Single Arm, Multicenter Study of Encorafenib, Binimetinib Plus Cetuximab in Subjects With Previously Untreated BRAF V600E -Mutant Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2019-01-17","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Pierre Fabre Medicament","sponsor_slug":"pierre-fabre-medicament","status":"reported-late","is_pact":false,"days_late":198},{"registry_id":"NCT03905694","publication_url":"https://clinicaltrials.gov/study/NCT03905694","title":"ILLUMINATE-B: An Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1","has_exemption":false,"start_date":"2019-04-22","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03990649","publication_url":"https://clinicaltrials.gov/study/NCT03990649","title":"A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Adult Subjects With Chronic Complex Regional Pain Syndrome","has_exemption":false,"start_date":"2019-07-23","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"Millennium Pharmaceuticals, Inc.","sponsor_slug":"millennium-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04368364","publication_url":"https://clinicaltrials.gov/study/NCT04368364","title":"A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks vs Intrathecal Morphine for Post Cesarean Section Pain","has_exemption":false,"start_date":"2020-05-22","completion_date":"2020-06-29","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported-late","is_pact":false,"days_late":266},{"registry_id":"NCT00854295","publication_url":"https://clinicaltrials.gov/study/NCT00854295","title":"Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee","has_exemption":false,"start_date":"2009-04-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"reported-late","is_pact":true,"days_late":237},{"registry_id":"NCT00980460","publication_url":"https://clinicaltrials.gov/study/NCT00980460","title":"Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment","has_exemption":false,"start_date":"2009-09-14","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":35},{"registry_id":"NCT01141023","publication_url":"https://clinicaltrials.gov/study/NCT01141023","title":"The Parkinson's Progression Markers Initiative (PPMI)","has_exemption":false,"start_date":"2010-06-30","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Ken Marek, MD","sponsor_slug":"ken-marek-md","status":"overdue","is_pact":true,"days_late":1765},{"registry_id":"NCT01341652","publication_url":"https://clinicaltrials.gov/study/NCT01341652","title":"Randomized Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP) Versus GM-CSF Adjuvant in Patients With Non-Metastatic Prostate Cancer","has_exemption":false,"start_date":"2011-05-23","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01372579","publication_url":"https://clinicaltrials.gov/study/NCT01372579","title":"Phase II Neoadjuvant Trial With Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients","has_exemption":false,"start_date":"2011-08-31","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported-late","is_pact":true,"days_late":904},{"registry_id":"NCT01697293","publication_url":"https://clinicaltrials.gov/study/NCT01697293","title":"A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Metastatic and Locally Advanced Breast Cancer","has_exemption":false,"start_date":"2012-01-31","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Prescient Therapeutics, Ltd.","sponsor_slug":"prescient-therapeutics-ltd","status":"overdue","is_pact":true,"days_late":1765},{"registry_id":"NCT01553149","publication_url":"https://clinicaltrials.gov/study/NCT01553149","title":"A Phase II Randomized Trial of Lenalidomide (NSC # 703813) in Pediatric Patients With Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas","has_exemption":false,"start_date":"2012-07-05","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":42},{"registry_id":"NCT01700673","publication_url":"https://clinicaltrials.gov/study/NCT01700673","title":"A Phase II Study of 5-Azacitidine (5AC) in Combination With Sargramostim (GM-CSF) as Maintenance Treatment, After Definitive Therapy With Either Stem Cell Transplant (SCT) or Cytarabine-based Chemotherapy, in Patients With Poor-risk Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2013-06-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported-late","is_pact":true,"days_late":37},{"registry_id":"NCT01983462","publication_url":"https://clinicaltrials.gov/study/NCT01983462","title":"Vascular Dysfunction in Human Obesity Hypertension: Integrative Role of Sympathetic and Renin-Angiotensin Systems","has_exemption":false,"start_date":"2013-10-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Gary L. Pierce","sponsor_slug":"gary-l-pierce","status":"reported-late","is_pact":true,"days_late":82},{"registry_id":"NCT02065869","publication_url":"https://clinicaltrials.gov/study/NCT02065869","title":"Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Family Donor After Negative Selection of TCRαβ+ T Cells in Paediatric Patients Affected by Haematological Disorders","has_exemption":true,"start_date":"2014-04-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Bellicum Pharmaceuticals","sponsor_slug":"bellicum-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01807897","publication_url":"https://clinicaltrials.gov/study/NCT01807897","title":"Oxygen Versus PAP for Treatment of Sleep Apnea in Chronic Heart Failure","has_exemption":true,"start_date":"2014-06-23","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02286843","publication_url":"https://clinicaltrials.gov/study/NCT02286843","title":"Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?","has_exemption":false,"start_date":"2014-11-06","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02293655","publication_url":"https://clinicaltrials.gov/study/NCT02293655","title":"The Effects of ADHD Medication (TEAM) Study: Neurobehavioral Effects of Abrupt Methylphenidate Discontinuation","has_exemption":false,"start_date":"2015-01-12","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported-late","is_pact":true,"days_late":153},{"registry_id":"NCT02408016","publication_url":"https://clinicaltrials.gov/study/NCT02408016","title":"Phase I/II Study in WT1-Expressing Non-small Cell Lung Cancer and Mesothelioma, Comparing Cellular Adoptive Immunotherapy With Polyclonal Autologous Central Memory to Naïve CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T-Cell Receptor","has_exemption":false,"start_date":"2015-05-22","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02309944","publication_url":"https://clinicaltrials.gov/study/NCT02309944","title":"Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients: A Randomized Controlled Trial","has_exemption":false,"start_date":"2015-05-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03068949","publication_url":"https://clinicaltrials.gov/study/NCT03068949","title":"A Comparison of CD4 T Cell Induction and Antibody Responses Between a Pure Hemagglutinin Influenza Vaccine and Licensed Subvirion Influenza Vaccine Made in Eggs or Cell Culture in Healthy Adults.","has_exemption":false,"start_date":"2015-10-28","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01675154","publication_url":"https://clinicaltrials.gov/study/NCT01675154","title":"Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia","has_exemption":false,"start_date":"2015-11-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02448381","publication_url":"https://clinicaltrials.gov/study/NCT02448381","title":"A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma","has_exemption":false,"start_date":"2015-12-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Soligenix","sponsor_slug":"soligenix","status":"reported-late","is_pact":true,"days_late":229},{"registry_id":"NCT02700152","publication_url":"https://clinicaltrials.gov/study/NCT02700152","title":"Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction","has_exemption":false,"start_date":"2016-01-31","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Syneron Medical","sponsor_slug":"syneron-medical","status":"overdue","is_pact":true,"days_late":1765},{"registry_id":"NCT04439318","publication_url":"https://clinicaltrials.gov/study/NCT04439318","title":"MATCH Treatment Subprotocol S1: Phase II Study of Trametinib in Patients With Tumors With NF1 Mutations","has_exemption":false,"start_date":"2016-02-25","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":742},{"registry_id":"NCT02660528","publication_url":"https://clinicaltrials.gov/study/NCT02660528","title":"Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder: An Open-Label Trial","has_exemption":false,"start_date":"2016-04-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03099863","publication_url":"https://clinicaltrials.gov/study/NCT03099863","title":"Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study","has_exemption":false,"start_date":"2016-04-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"MetroHealth Medical Center","sponsor_slug":"metrohealth-medical-center","status":"reported-late","is_pact":true,"days_late":110},{"registry_id":"NCT03116945","publication_url":"https://clinicaltrials.gov/study/NCT03116945","title":"68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma","has_exemption":false,"start_date":"2016-06-30","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"reported-late","is_pact":true,"days_late":78},{"registry_id":"NCT02803229","publication_url":"https://clinicaltrials.gov/study/NCT02803229","title":"Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2016-07-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02728102","publication_url":"https://clinicaltrials.gov/study/NCT02728102","title":"Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma With or Without Vaccination With Dendritic Cell/Myeloma Fusions (BMT CTN 1401)","has_exemption":false,"start_date":"2016-07-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"reported-late","is_pact":true,"days_late":9},{"registry_id":"NCT02819440","publication_url":"https://clinicaltrials.gov/study/NCT02819440","title":"PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction","has_exemption":true,"start_date":"2016-07-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02867618","publication_url":"https://clinicaltrials.gov/study/NCT02867618","title":"Phase I/II Study of Carfilzomib and a PI3Kdelta Inhibitor TGR-1202 in the Treatment of Patients With Relapsed or Refractory Lymphoma","has_exemption":false,"start_date":"2016-10-16","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02564796","publication_url":"https://clinicaltrials.gov/study/NCT02564796","title":"Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial","has_exemption":false,"start_date":"2016-11-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported-late","is_pact":true,"days_late":126},{"registry_id":"NCT02913924","publication_url":"https://clinicaltrials.gov/study/NCT02913924","title":"Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients: Combined Inpatient/Outpatient Study","has_exemption":false,"start_date":"2016-12-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03015246","publication_url":"https://clinicaltrials.gov/study/NCT03015246","title":"Biobehavioral Studies of Opioid Seeking: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence","has_exemption":false,"start_date":"2016-12-31","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"overdue","is_pact":true,"days_late":1765},{"registry_id":"NCT03733249","publication_url":"https://clinicaltrials.gov/study/NCT03733249","title":"Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders","has_exemption":false,"start_date":"2017-01-31","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Bellicum Pharmaceuticals","sponsor_slug":"bellicum-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":722},{"registry_id":"NCT02898077","publication_url":"https://clinicaltrials.gov/study/NCT02898077","title":"A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine","has_exemption":false,"start_date":"2017-03-02","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03965351","publication_url":"https://clinicaltrials.gov/study/NCT03965351","title":"TRPV2 Agonists in Fontan Circulation Patients","has_exemption":false,"start_date":"2017-03-21","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02962895","publication_url":"https://clinicaltrials.gov/study/NCT02962895","title":"Study of Safety and Efficacy of Multiple VAY736 Doses in Patients With Moderate to Severe Primary Sjogren's Syndrome (pSS)","has_exemption":true,"start_date":"2017-06-27","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03747614","publication_url":"https://clinicaltrials.gov/study/NCT03747614","title":"Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy","has_exemption":false,"start_date":"2017-06-30","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","sponsor_slug":"zhongshan-ophthalmic-center-sun-yat-sen-university","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04014959","publication_url":"https://clinicaltrials.gov/study/NCT04014959","title":"Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI in MDD Patients","has_exemption":false,"start_date":"2017-07-14","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported-late","is_pact":false,"days_late":323},{"registry_id":"NCT03178201","publication_url":"https://clinicaltrials.gov/study/NCT03178201","title":"Study of the Phosphoinositide-3-Kinase-Delta Inhibitor TGR-1202 in Patients With Relapsed or Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2017-08-20","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03277690","publication_url":"https://clinicaltrials.gov/study/NCT03277690","title":"A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome","has_exemption":true,"start_date":"2017-09-26","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Cortendo AB","sponsor_slug":"cortendo-ab","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04332718","publication_url":"https://clinicaltrials.gov/study/NCT04332718","title":"Smartphone Electrocardiogram for Recording Atrial Fibrillation After a Cerebral Ischemic Event: A Randomised Controlled Trial","has_exemption":false,"start_date":"2017-11-15","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Sarawak Heart Centre","sponsor_slug":"sarawak-heart-centre","status":"reported-late","is_pact":false,"days_late":522},{"registry_id":"NCT03523715","publication_url":"https://clinicaltrials.gov/study/NCT03523715","title":"Effect of Prunes on Gastrointestinal Function After Gynecological Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2017-11-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03338569","publication_url":"https://clinicaltrials.gov/study/NCT03338569","title":"Evaluating Vitamin C in Septic Shock: A Randomized Double Blind Placebo Controlled Trial","has_exemption":false,"start_date":"2017-12-20","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03683017","publication_url":"https://clinicaltrials.gov/study/NCT03683017","title":"OrthoPulse 2.0 and 2.1 Product Evaluation and Assessing Clinical Effectiveness: A Feasibility Study","has_exemption":false,"start_date":"2017-12-22","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Biolux Research Holdings, Inc.","sponsor_slug":"biolux-research-holdings-inc","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03239392","publication_url":"https://clinicaltrials.gov/study/NCT03239392","title":"A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients With Large Granular Lymphocyte Leukemia or Refractory Cutaneous T-Cell Lymphoma","has_exemption":false,"start_date":"2018-04-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Bioniz Therapeutics","sponsor_slug":"bioniz-therapeutics","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03030248","publication_url":"https://clinicaltrials.gov/study/NCT03030248","title":"Randomized Double Blind Controlled Trial for the Treatment of Nucleic Acid Amplification Test (NAAT)+/Toxin Enzyme Immunoassay (EIA)- Clostridium Difficile in the Hematology Oncology Population","has_exemption":false,"start_date":"2018-06-01","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"reported-late","is_pact":false,"days_late":145},{"registry_id":"NCT03573102","publication_url":"https://clinicaltrials.gov/study/NCT03573102","title":"Effect of SGLT2 Inhibitor on Proteinuria in Diabetic Patients","has_exemption":false,"start_date":"2018-06-20","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Nahla H Tohami","sponsor_slug":"nahla-h-tohami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03265717","publication_url":"https://clinicaltrials.gov/study/NCT03265717","title":"A Phase II Study of INVAC-1 as Treatment of Patients With High-risk Chronic Lymphocytic Leukemia","has_exemption":false,"start_date":"2018-07-25","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Invectys","sponsor_slug":"invectys","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03542110","publication_url":"https://clinicaltrials.gov/study/NCT03542110","title":"Effect of Alirocumab on Saphenous Vein Graft Atherosclerosis: The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial","has_exemption":false,"start_date":"2018-08-04","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Minneapolis Heart Institute Foundation","sponsor_slug":"minneapolis-heart-institute-foundation","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03331302","publication_url":"https://clinicaltrials.gov/study/NCT03331302","title":"Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy","has_exemption":false,"start_date":"2018-09-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"reported-late","is_pact":false,"days_late":247},{"registry_id":"NCT03654326","publication_url":"https://clinicaltrials.gov/study/NCT03654326","title":"A Phase 2a, Proof of Concept, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK-7264 in Women With Moderate to Severe Endometriosis-Related Pain","has_exemption":false,"start_date":"2018-09-11","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02765282","publication_url":"https://clinicaltrials.gov/study/NCT02765282","title":"Automated Deep Brain Stimulation Programming Using Functional Mapping","has_exemption":false,"start_date":"2018-10-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Great Lakes NeuroTechnologies Inc.","sponsor_slug":"great-lakes-neurotechnologies-inc","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03467217","publication_url":"https://clinicaltrials.gov/study/NCT03467217","title":"Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial","has_exemption":false,"start_date":"2018-10-02","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03661983","publication_url":"https://clinicaltrials.gov/study/NCT03661983","title":"A Randomized, Placebo-controlled Trial to Evaluate the Long-term (ie, Maintenance) Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder","has_exemption":false,"start_date":"2018-10-13","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04093843","publication_url":"https://clinicaltrials.gov/study/NCT04093843","title":"Accelerated rTMS as a Treatment for Post-stroke Depression in the Subacute Phase: an Open Label Pilot Study","has_exemption":false,"start_date":"2018-10-24","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Amelia Adcock","sponsor_slug":"amelia-adcock","status":"reported-late","is_pact":false,"days_late":103},{"registry_id":"NCT03584100","publication_url":"https://clinicaltrials.gov/study/NCT03584100","title":"The Effect of Pneumatic Tourniquet Use on Upper Extremity Edema Following Axillary Lymph Node Dissection","has_exemption":false,"start_date":"2018-11-07","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04132674","publication_url":"https://clinicaltrials.gov/study/NCT04132674","title":"Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed","has_exemption":false,"start_date":"2018-11-26","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Vancouver Infectious Diseases Centre","sponsor_slug":"vancouver-infectious-diseases-centre","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03607643","publication_url":"https://clinicaltrials.gov/study/NCT03607643","title":"Randomized Double-Blind, Placebo-Controlled Parallel Multi-Center Study to Assess the Efficacy of Cannabidiol (BRCX014) Combined With Standard-Of-Care Treatment in Subjects With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies","has_exemption":false,"start_date":"2019-01-15","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Leaf Vertical Inc.","sponsor_slug":"leaf-vertical-inc","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03817606","publication_url":"https://clinicaltrials.gov/study/NCT03817606","title":"A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant on Spinal Fusion in Patients With Degenerative Disc Disease","has_exemption":false,"start_date":"2019-03-01","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Riverside Medical Center","sponsor_slug":"riverside-medical-center","status":"reported-late","is_pact":false,"days_late":91},{"registry_id":"NCT04015739","publication_url":"https://clinicaltrials.gov/study/NCT04015739","title":"A GINECO Phase II Trialo Assessing the Safety and the Efficacy of the Bevacizumab, Olaparib and Durvalumab (MEDI 4736) Combination in Patients With Advanced Epithelial Ovarian Cancer in Relapse","has_exemption":false,"start_date":"2019-03-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"ARCAGY/ GINECO GROUP","sponsor_slug":"arcagy-gineco-group","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04326270","publication_url":"https://clinicaltrials.gov/study/NCT04326270","title":"Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs","has_exemption":false,"start_date":"2019-03-07","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Arkansas Children's Hospital Research Institute","sponsor_slug":"arkansas-childrens-hospital-research-institute","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04820153","publication_url":"https://clinicaltrials.gov/study/NCT04820153","title":"Monitoring Physical Activity in Hispanic Women With Chronic Neurological Disorders","has_exemption":false,"start_date":"2019-03-26","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"reported-late","is_pact":false,"days_late":139},{"registry_id":"NCT04272255","publication_url":"https://clinicaltrials.gov/study/NCT04272255","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of DPI-386 Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness","has_exemption":false,"start_date":"2019-04-22","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Repurposed Therapeutics, Inc.","sponsor_slug":"repurposed-therapeutics-inc","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03901417","publication_url":"https://clinicaltrials.gov/study/NCT03901417","title":"A Randomized, Double-blind, Split-face Controlled Pilot Study to Assess the Efficacy of Combination Microneedling and Non-ablative Fractional Laser Versus Non-ablative Fractional Laser Alone for Treatment of Atrophic Acne Scars","has_exemption":false,"start_date":"2019-06-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT03722576","publication_url":"https://clinicaltrials.gov/study/NCT03722576","title":"Investigation of the Activity of Vidofludimus Calcium, a Novel, Orally Available, Small Molecule Inhibitor of Dihydroorotate Dehydrogenase, as a Treatment for Primary Sclerosing Cholangitis (PSC)","has_exemption":false,"start_date":"2019-06-17","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Elizabeth Carey","sponsor_slug":"elizabeth-carey","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03678402","publication_url":"https://clinicaltrials.gov/study/NCT03678402","title":"Testing the Effectiveness of a Falls Prevention System","has_exemption":false,"start_date":"2019-06-24","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Tammy Moore","sponsor_slug":"tammy-moore","status":"reported-late","is_pact":false,"days_late":30},{"registry_id":"NCT04005755","publication_url":"https://clinicaltrials.gov/study/NCT04005755","title":"A Phase 3, Open-Label, Multiple-Dose, Single-Arm Exposure Study of Maxigesic® IV in Patients With Acute Pain Following Orthopedic, General or Plastic Surgery","has_exemption":false,"start_date":"2019-07-22","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"AFT Pharmaceuticals, Ltd.","sponsor_slug":"aft-pharmaceuticals-ltd","status":"reported-late","is_pact":false,"days_late":7},{"registry_id":"NCT04001517","publication_url":"https://clinicaltrials.gov/study/NCT04001517","title":"A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)","has_exemption":false,"start_date":"2019-09-30","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02661919","publication_url":"https://clinicaltrials.gov/study/NCT02661919","title":"Assessment of the Emfit Mattress Sensor (L-4060SLC) and Monitor (DVM-GPRS-V2) and Their Acoustic and Cloud Interface Notification Capabilities as a Nocturnal Detection System for Movements Associated With Generalized Tonic-clonic Seizures.","has_exemption":false,"start_date":"2019-10-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Emfit, Corp.","sponsor_slug":"emfit-corp","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04871581","publication_url":"https://clinicaltrials.gov/study/NCT04871581","title":"Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device: Overview and Results of a Placebo-Controlled Crossover Study","has_exemption":false,"start_date":"2019-10-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"ChairsideSplint.com","sponsor_slug":"chairsidesplintcom","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04021862","publication_url":"https://clinicaltrials.gov/study/NCT04021862","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":true,"start_date":"2019-10-16","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04147611","publication_url":"https://clinicaltrials.gov/study/NCT04147611","title":"Remote Microphone (RM) Technology in Children Using Bone Conduction Devices: A Comparative Study","has_exemption":false,"start_date":"2019-10-21","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04205916","publication_url":"https://clinicaltrials.gov/study/NCT04205916","title":"A Prospective Trial Evaluating a Intracanalicular Insert Delivery System Compared to Traditional Topical Drops in Controlling Post-operative Pain and inFlammation in Subjects Undergoing Sequential Bilateral Cataract Surgery","has_exemption":false,"start_date":"2019-11-04","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Ophthalmic Consultants of Long Island","sponsor_slug":"ophthalmic-consultants-of-long-island","status":"reported-late","is_pact":false,"days_late":775},{"registry_id":"NCT04121143","publication_url":"https://clinicaltrials.gov/study/NCT04121143","title":"Multicenter, Placebo-controlled, Parallel-randomized, Double-blind, Phase II Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of SHR-1314 Injection With Moderate to Severe Plaque Psoriasis in Adults","has_exemption":false,"start_date":"2019-11-09","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","sponsor_slug":"jiangsu-hengrui-medicine-co-ltd","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04297241","publication_url":"https://clinicaltrials.gov/study/NCT04297241","title":"Nitrate Effect on Exercise Capacitance and Hemodynamic Profile Prior to Fontan Failure","has_exemption":false,"start_date":"2019-12-12","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported-late","is_pact":false,"days_late":9},{"registry_id":"NCT04333225","publication_url":"https://clinicaltrials.gov/study/NCT04333225","title":"A Prospective Clinical Study of Hydroxychloroquine in the Prevention of SARS- CoV-2 (COVID-19) Infection in Healthcare Workers After High-risk Exposures","has_exemption":false,"start_date":"2020-04-03","completion_date":"2020-06-30","has_results":true,"results_due":true,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT04356508","publication_url":"https://clinicaltrials.gov/study/NCT04356508","title":"COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1","has_exemption":false,"start_date":"2020-04-14","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Dr Gerry Gin Wai Kwok","sponsor_slug":"dr-gerry-gin-wai-kwok","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04277949","publication_url":"https://clinicaltrials.gov/study/NCT04277949","title":"Effects of 2,940-nm Fractional Ablative Erbium and Topical DNA Repair Enzymes on p53 Epidermal Expression After 3 Months: A Comparative Clinical Trial","has_exemption":false,"start_date":"2020-04-30","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Moy-Fincher-Chipps Facial Plastics and Dermatology","sponsor_slug":"moy-fincher-chipps-facial-plastics-and-dermatology","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04739410","publication_url":"https://clinicaltrials.gov/study/NCT04739410","title":"Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients","has_exemption":false,"start_date":"2020-05-01","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"FMH College of Medicine and Dentistry","sponsor_slug":"fmh-college-of-medicine-and-dentistry","status":"overdue","is_pact":false,"days_late":1765},{"registry_id":"NCT04396327","publication_url":"https://clinicaltrials.gov/study/NCT04396327","title":"A Randomized, Double-Blind, Single-Dose, 2-Way Cross-Over Study to Assess the Pharmacodynamic Effects of SM-1 vs. Active Comparator in a 3-Hour Phase Advance Model of Transient Insomnia","has_exemption":false,"start_date":"2020-05-27","completion_date":"2020-06-30","has_results":false,"results_due":true,"sponsor_name":"Sequential Medicine Ltd","sponsor_slug":"sequential-medicine-ltd","status":"reported-late","is_pact":false,"days_late":673},{"registry_id":"NCT02301039","publication_url":"https://clinicaltrials.gov/study/NCT02301039","title":"SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas","has_exemption":false,"start_date":"2015-03-31","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Sarcoma Alliance for Research through Collaboration","sponsor_slug":"sarcoma-alliance-for-research-through-collaboration","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02127658","publication_url":"https://clinicaltrials.gov/study/NCT02127658","title":"MRSA Eradication and Decolonization in Children","has_exemption":false,"start_date":"2016-02-18","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":true,"days_late":606},{"registry_id":"NCT02655692","publication_url":"https://clinicaltrials.gov/study/NCT02655692","title":"CAP-Ketamine for Antidepressant Resistant PTSD","has_exemption":false,"start_date":"2016-04-18","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported-late","is_pact":true,"days_late":116},{"registry_id":"NCT02765165","publication_url":"https://clinicaltrials.gov/study/NCT02765165","title":"A Phase 1/2 Dose-escalation of USL311 as Single Agent and in Combination With Lomustine (CCNU) in Subjects With Advanced Solid Tumors, With Subsequent Single Agent and Combination Phase 2 Cohorts for Subjects With Relapsed/Recurrent Glioblastoma Multiforme (GBM)","has_exemption":false,"start_date":"2016-04-30","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Proximagen, LLC","sponsor_slug":"proximagen-llc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02687451","publication_url":"https://clinicaltrials.gov/study/NCT02687451","title":"An Open-Label Single-Dose And Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oxymorphone Hydrochloride (HCl) For Acute Moderate To Severe Postoperative Pain In Pediatric Subjects","has_exemption":false,"start_date":"2016-04-30","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Endo Pharmaceuticals","sponsor_slug":"endo-pharmaceuticals","status":"reported-late","is_pact":true,"days_late":40},{"registry_id":"NCT02904226","publication_url":"https://clinicaltrials.gov/study/NCT02904226","title":"Phase 1/2 Multicenter Trial of ICOS Agonist Monoclonal Antibody (mAb) JTX-2011 Alone and in Combination With Nivolumab, Ipilimumab, or Pembrolizumab in Adult Subjects With Advanced and/or Refractory Solid Tumor Malignancies","has_exemption":false,"start_date":"2016-08-31","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Jounce Therapeutics, Inc.","sponsor_slug":"jounce-therapeutics-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03122301","publication_url":"https://clinicaltrials.gov/study/NCT03122301","title":"Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer: A Pilot Randomized Sham-Controlled Trial","has_exemption":false,"start_date":"2017-06-01","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported-late","is_pact":false,"days_late":287},{"registry_id":"NCT03466827","publication_url":"https://clinicaltrials.gov/study/NCT03466827","title":"A Phase II Study of Selinexor (KPT-330) in Patients With Advanced Thymic Epithelial Tumour (TET) Progressing After Primary Chemotherapy.","has_exemption":false,"start_date":"2017-10-12","completion_date":"2020-07-01","has_results":false,"results_due":true,"sponsor_name":"Morten Mau-Soerensen","sponsor_slug":"morten-mau-soerensen","status":"overdue","is_pact":false,"days_late":1764},{"registry_id":"NCT03171480","publication_url":"https://clinicaltrials.gov/study/NCT03171480","title":"Randomized Controlled Trial of Nitric-oxide Donor (NOD) Isosorbide Mononitrate (IMN) Versus Placebo for Induction of Labor in Pregnancies Complicated by Preeclampsia","has_exemption":false,"start_date":"2017-10-30","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"reported-late","is_pact":false,"days_late":35},{"registry_id":"NCT03277352","publication_url":"https://clinicaltrials.gov/study/NCT03277352","title":"A Phase 1/2 Safety and Efficacy Study of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies","has_exemption":false,"start_date":"2017-11-21","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Incyte Biosciences International Sàrl","sponsor_slug":"incyte-biosciences-international-sarl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03430609","publication_url":"https://clinicaltrials.gov/study/NCT03430609","title":"Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma: A Randomized Control Trial","has_exemption":false,"start_date":"2018-04-01","completion_date":"2020-07-01","has_results":false,"results_due":true,"sponsor_name":"Faculdade de Ciências Médicas da Santa Casa de São Paulo","sponsor_slug":"faculdade-de-ciencias-medicas-da-santa-casa-de-sao-paulo","status":"reported-late","is_pact":false,"days_late":7},{"registry_id":"NCT03576833","publication_url":"https://clinicaltrials.gov/study/NCT03576833","title":"The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study","has_exemption":false,"start_date":"2018-05-15","completion_date":"2020-07-01","has_results":false,"results_due":true,"sponsor_name":"Norwegian Department of Health and Social Affairs","sponsor_slug":"norwegian-department-of-health-and-social-affairs","status":"overdue","is_pact":false,"days_late":1764},{"registry_id":"NCT03605914","publication_url":"https://clinicaltrials.gov/study/NCT03605914","title":"Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty","has_exemption":false,"start_date":"2018-08-01","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03615469","publication_url":"https://clinicaltrials.gov/study/NCT03615469","title":"Building Strength Through Rehabilitation for Heart Failure Patients","has_exemption":false,"start_date":"2018-09-06","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04233008","publication_url":"https://clinicaltrials.gov/study/NCT04233008","title":"Length of Cook Catheter Placement and Induction of Labor: a Randomized Controlled Trial","has_exemption":false,"start_date":"2019-01-01","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":false,"days_late":236},{"registry_id":"NCT03579407","publication_url":"https://clinicaltrials.gov/study/NCT03579407","title":"Traditional Open Ended Trocar vs. Fenestrated Blunt Trocar in Bone Marrow Aspirate for Osteoarthritis: A Randomized Controlled Trial","has_exemption":false,"start_date":"2019-01-10","completion_date":"2020-07-01","has_results":false,"results_due":true,"sponsor_name":"Advanced Orthopaedic Specialists","sponsor_slug":"advanced-orthopaedic-specialists","status":"overdue","is_pact":false,"days_late":1764},{"registry_id":"NCT03589768","publication_url":"https://clinicaltrials.gov/study/NCT03589768","title":"A Phase II Double-Blind Trial to Evaluate the Safety, Immunogenicity and Effect on Infant Immune Responses of a Single Dose of Tdap in Pregnant Women in Mali","has_exemption":true,"start_date":"2019-01-24","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03691727","publication_url":"https://clinicaltrials.gov/study/NCT03691727","title":"A Phase 1/2a Exploratory Clinical Trial: Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)","has_exemption":false,"start_date":"2019-01-24","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"David Hasan","sponsor_slug":"david-hasan","status":"reported-late","is_pact":false,"days_late":41},{"registry_id":"NCT04339972","publication_url":"https://clinicaltrials.gov/study/NCT04339972","title":"Low Intensity Focused Ultrasound Pulses (LIFUP) to Modulate Pain","has_exemption":false,"start_date":"2019-02-01","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03783702","publication_url":"https://clinicaltrials.gov/study/NCT03783702","title":"Multi-institutional, Randomized Controlled Trial Assessing Opioid Use and Analgesic Requirements After Endoscopic Sinus Surgery","has_exemption":false,"start_date":"2019-04-04","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":false,"days_late":15},{"registry_id":"NCT03889704","publication_url":"https://clinicaltrials.gov/study/NCT03889704","title":"Neuromuscular Electrical Stimulation for Jaw-closing Dystonia","has_exemption":false,"start_date":"2019-05-16","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Edward Burton","sponsor_slug":"edward-burton","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05155540","publication_url":"https://clinicaltrials.gov/study/NCT05155540","title":"A Comparative Study of The Efficacy and Safety of Direct Mechanical Thrombectomy Versus Bridging Therapy in Large Vessel Occlusion: An Egyptian Single-Center Experience","has_exemption":false,"start_date":"2019-07-01","completion_date":"2020-07-01","has_results":false,"results_due":true,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"overdue","is_pact":false,"days_late":1764},{"registry_id":"NCT04051463","publication_url":"https://clinicaltrials.gov/study/NCT04051463","title":"Prospective Randomized Study to Determine Whether Use of Rhopressa™ Can Ameliorate Corneal Edema Associated With Fuchs Dystrophy","has_exemption":false,"start_date":"2019-08-05","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Price Vision Group","sponsor_slug":"price-vision-group","status":"reported-late","is_pact":false,"days_late":57},{"registry_id":"NCT04185246","publication_url":"https://clinicaltrials.gov/study/NCT04185246","title":"A Multicenter, Open-Label, Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography","has_exemption":true,"start_date":"2019-11-04","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Trust Bio-sonics, Inc.","sponsor_slug":"trust-bio-sonics-inc","status":"reported-late","is_pact":false,"days_late":515},{"registry_id":"NCT04079881","publication_url":"https://clinicaltrials.gov/study/NCT04079881","title":"Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes","has_exemption":false,"start_date":"2020-02-13","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04329832","publication_url":"https://clinicaltrials.gov/study/NCT04329832","title":"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (HAHPS): A Prospective Pragmatic Trial","has_exemption":false,"start_date":"2020-03-30","completion_date":"2020-07-01","has_results":true,"results_due":true,"sponsor_name":"Intermountain Health Care, Inc.","sponsor_slug":"intermountain-health-care-inc","status":"reported-late","is_pact":false,"days_late":256},{"registry_id":"NCT02600507","publication_url":"https://clinicaltrials.gov/study/NCT02600507","title":"Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder","has_exemption":false,"start_date":"2016-03-07","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"reported-late","is_pact":true,"days_late":661},{"registry_id":"NCT02827877","publication_url":"https://clinicaltrials.gov/study/NCT02827877","title":"Use of 64Cu-DOTA-Trastuzumab PET Imaging and Molecular Markers for Prediction of Response to Trastuzumab and Pertuzum-Based Neoadjuvant Therapy","has_exemption":false,"start_date":"2016-07-15","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"reported-late","is_pact":true,"days_late":96},{"registry_id":"NCT06103656","publication_url":"https://clinicaltrials.gov/study/NCT06103656","title":"Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety and Efficacy of Chinese Herbal Therapy and Multiple Food Allergen Oral Immunotherapy","has_exemption":false,"start_date":"2016-08-20","completion_date":"2020-07-02","has_results":false,"results_due":true,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"overdue","is_pact":true,"days_late":1763},{"registry_id":"NCT02720185","publication_url":"https://clinicaltrials.gov/study/NCT02720185","title":"Window of Opportunity Study of Dasatinib in Operable Triple Negative Breast Cancers With Nuclear Epidermal Growth Factor Receptor (nEGFR)","has_exemption":true,"start_date":"2017-05-03","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03189719","publication_url":"https://clinicaltrials.gov/study/NCT03189719","title":"A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial of Pembrolizumab (MK-3475) in Combination With Cisplatin and 5-Fluorouracil Versus Placebo in Combination With Cisplatin and 5-Fluorouracil as First-Line Treatment in Subjects With Advanced/Metastatic Esophageal Carcinoma (KEYNOTE-590)","has_exemption":false,"start_date":"2017-07-25","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03270332","publication_url":"https://clinicaltrials.gov/study/NCT03270332","title":"Effect of Inhaled Albuterol on Pulmonary Hemodynamics in Patients With Group 1 Pulmonary Arterial Hypertension on Oral Pulmonary Vasodilator Therapy: A Proof of Concept Study","has_exemption":false,"start_date":"2017-10-05","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT03275922","publication_url":"https://clinicaltrials.gov/study/NCT03275922","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Evaluate The Efficacy And Safety Of Zolmitriptan Nasal Spray For The Treatment Of Acute Migraine In Subjects Ages 6 To 11 Years, With An Open-Label Extension","has_exemption":false,"start_date":"2017-11-27","completion_date":"2020-07-02","has_results":false,"results_due":true,"sponsor_name":"Impax Laboratories, LLC","sponsor_slug":"impax-laboratories-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03329846","publication_url":"https://clinicaltrials.gov/study/NCT03329846","title":"A Phase 3, Randomized, Double-blind Study of BMS-986205 Combined With Nivolumab Versus Nivolumab in Participants With Metastatic or Unresectable Melanoma That is Previously Untreated","has_exemption":false,"start_date":"2017-11-30","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03472521","publication_url":"https://clinicaltrials.gov/study/NCT03472521","title":"Prevention of Persistent Pain and Opioid Use in Mothers - POMS","has_exemption":false,"start_date":"2018-09-17","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":false,"days_late":73},{"registry_id":"NCT03712371","publication_url":"https://clinicaltrials.gov/study/NCT03712371","title":"Phase 1b/2 Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients","has_exemption":true,"start_date":"2019-01-16","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04063865","publication_url":"https://clinicaltrials.gov/study/NCT04063865","title":"Protection of Renal Function After Liver Transplant Using Everolimus Monotherapy as the Immunosuppression Regimen","has_exemption":false,"start_date":"2019-05-09","completion_date":"2020-07-02","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":false,"days_late":46},{"registry_id":"NCT02424968","publication_url":"https://clinicaltrials.gov/study/NCT02424968","title":"Post Transplant Infusion of Allogeneic CD8 Memory T-Cells as Consolidative Therapy After Non-myeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Leukemia and Lymphoma","has_exemption":false,"start_date":"2015-06-30","completion_date":"2020-07-03","has_results":true,"results_due":true,"sponsor_name":"Robert Lowsky","sponsor_slug":"robert-lowsky","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02559505","publication_url":"https://clinicaltrials.gov/study/NCT02559505","title":"Understanding How the Initial Encounter With Influenza Virus Poises Children for Protective Immunity","has_exemption":false,"start_date":"2015-10-31","completion_date":"2020-07-03","has_results":true,"results_due":true,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"reported-late","is_pact":true,"days_late":33},{"registry_id":"NCT03183128","publication_url":"https://clinicaltrials.gov/study/NCT03183128","title":"A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults","has_exemption":true,"start_date":"2017-07-10","completion_date":"2020-07-03","has_results":true,"results_due":true,"sponsor_name":"Seres Therapeutics, Inc.","sponsor_slug":"seres-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03730129","publication_url":"https://clinicaltrials.gov/study/NCT03730129","title":"A Prospective Case Series of Subcutaneous Immunoglobulin for Prophylaxis of Infections in Patients With Chronic Lymphocytic Leukemia With Impaired Humoral Immunity","has_exemption":false,"start_date":"2018-11-05","completion_date":"2020-07-03","has_results":false,"results_due":true,"sponsor_name":"Rochester General Hospital","sponsor_slug":"rochester-general-hospital","status":"overdue","is_pact":false,"days_late":1762},{"registry_id":"NCT03805412","publication_url":"https://clinicaltrials.gov/study/NCT03805412","title":"A Pilot Study on the Use of Real-Time Continuous Glucose Monitoring (RT-CGM) as an Educational Tool for Patients With Prediabetes and Diabetes","has_exemption":false,"start_date":"2019-01-10","completion_date":"2020-07-03","has_results":true,"results_due":true,"sponsor_name":"Nicole Ehrhardt, MD","sponsor_slug":"nicole-ehrhardt-md","status":"reported-late","is_pact":false,"days_late":69},{"registry_id":"NCT03395353","publication_url":"https://clinicaltrials.gov/study/NCT03395353","title":"A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder","has_exemption":false,"start_date":"2018-01-29","completion_date":"2020-07-04","has_results":true,"results_due":true,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03320057","publication_url":"https://clinicaltrials.gov/study/NCT03320057","title":"Alternative Provision of Medication Abortion Via Pharmacy Dispensing","has_exemption":false,"start_date":"2018-06-01","completion_date":"2020-07-04","has_results":true,"results_due":true,"sponsor_name":"Daniel Grossman","sponsor_slug":"daniel-grossman","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02551159","publication_url":"https://clinicaltrials.gov/study/NCT02551159","title":"A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination With Tremelimumab Versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients","has_exemption":false,"start_date":"2015-10-15","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02690558","publication_url":"https://clinicaltrials.gov/study/NCT02690558","title":"Phase II Single Arm Study of Gemcitabine and Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Prior to Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer","has_exemption":false,"start_date":"2016-05-31","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"reported-late","is_pact":true,"days_late":9},{"registry_id":"NCT03098550","publication_url":"https://clinicaltrials.gov/study/NCT03098550","title":"Phase 1/2 Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab Combined With Daratumumab in Participants With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2017-06-15","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03283072","publication_url":"https://clinicaltrials.gov/study/NCT03283072","title":"Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults","has_exemption":false,"start_date":"2017-09-18","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02973087","publication_url":"https://clinicaltrials.gov/study/NCT02973087","title":"A PROSPECTIVE, PHASE 3, OPEN-LABEL, INTERNATIONAL MULTICENTER STUDY ON EFFICACY AND SAFETY OF PROPHYLAXIS WITH rVWF IN SEVERE VON WILLEBRAND DISEASE","has_exemption":false,"start_date":"2017-11-16","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03676751","publication_url":"https://clinicaltrials.gov/study/NCT03676751","title":"Gut and Azithromycin Mechanisms in Infants and Neonates","has_exemption":true,"start_date":"2019-10-10","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04787627","publication_url":"https://clinicaltrials.gov/study/NCT04787627","title":"Clinical Investigation (Beta) of Power Knee","has_exemption":false,"start_date":"2019-11-18","completion_date":"2020-07-06","has_results":true,"results_due":true,"sponsor_name":"Össur Iceland ehf","sponsor_slug":"ossur-iceland-ehf","status":"reported-late","is_pact":false,"days_late":1266},{"registry_id":"NCT01173692","publication_url":"https://clinicaltrials.gov/study/NCT01173692","title":"Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.","has_exemption":false,"start_date":"2010-07-22","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02406742","publication_url":"https://clinicaltrials.gov/study/NCT02406742","title":"Phase 1/2 Study to Determine the Safety, Pharmacokinetics, and Efficacy of Single Agent CC-122 and the Combinations CC-122 AND Ibrutinib and CC-122 and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2015-07-27","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03041025","publication_url":"https://clinicaltrials.gov/study/NCT03041025","title":"A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis","has_exemption":false,"start_date":"2017-06-05","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03180528","publication_url":"https://clinicaltrials.gov/study/NCT03180528","title":"A Phase 2 Open-Label, Single-Arm Trial of the Efficacy of Topical Remetinostat on Basal Cell Carcinoma in Patients","has_exemption":false,"start_date":"2018-07-07","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"Kavita Sarin","sponsor_slug":"kavita-sarin","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03559517","publication_url":"https://clinicaltrials.gov/study/NCT03559517","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)","has_exemption":false,"start_date":"2018-08-29","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"Shire","sponsor_slug":"shire","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04450381","publication_url":"https://clinicaltrials.gov/study/NCT04450381","title":"Noninvasive Hemoglobin Testing in Prospective Blood Donors","has_exemption":false,"start_date":"2020-06-23","completion_date":"2020-07-07","has_results":true,"results_due":true,"sponsor_name":"Masimo Corporation","sponsor_slug":"masimo-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00587301","publication_url":"https://clinicaltrials.gov/study/NCT00587301","title":"A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Lap-Band® Adjustable Gastric Band (LAGB®) Operations in the Treatment of Morbidly Obese Adolescents (Ages 14-17)","has_exemption":false,"start_date":"2005-06-30","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported-late","is_pact":true,"days_late":180},{"registry_id":"NCT00925002","publication_url":"https://clinicaltrials.gov/study/NCT00925002","title":"OPEN-LABEL SAFETY AND EFFICACY EVALUATION OF FX-1006A IN SUBJECTS WITH TRANSTHYRETIN (TTR) AMYLOIDOSIS","has_exemption":false,"start_date":"2009-08-05","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01831895","publication_url":"https://clinicaltrials.gov/study/NCT01831895","title":"CALM-FIM_US -Controlling and Lowering Blood Pressure With the MobiusHD™ - A Prospective Multicenter Safety Study","has_exemption":true,"start_date":"2013-05-31","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Vascular Dynamics, Inc.","sponsor_slug":"vascular-dynamics-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03185013","publication_url":"https://clinicaltrials.gov/study/NCT03185013","title":"A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix","has_exemption":true,"start_date":"2017-06-28","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Inovio Pharmaceuticals","sponsor_slug":"inovio-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03285308","publication_url":"https://clinicaltrials.gov/study/NCT03285308","title":"A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis","has_exemption":false,"start_date":"2017-09-29","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03315143","publication_url":"https://clinicaltrials.gov/study/NCT03315143","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function","has_exemption":true,"start_date":"2017-12-19","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Lexicon Pharmaceuticals","sponsor_slug":"lexicon-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03478787","publication_url":"https://clinicaltrials.gov/study/NCT03478787","title":"A Multicenter, Randomized, Open Label, Efficacy Assessor-Blinded Study of Risankizumab Compared to Secukinumab for the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy","has_exemption":false,"start_date":"2018-05-08","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05241145","publication_url":"https://clinicaltrials.gov/study/NCT05241145","title":"A Randomized, Controlled, Double-Masked Evaluation of the Safety and Preliminary Efficacy of IVMED-80 on Keratoconus Progression","has_exemption":false,"start_date":"2019-02-08","completion_date":"2020-07-08","has_results":false,"results_due":true,"sponsor_name":"iVeena Delivery Systems, Inc.","sponsor_slug":"iveena-delivery-systems-inc","status":"reported-late","is_pact":false,"days_late":231},{"registry_id":"NCT03874715","publication_url":"https://clinicaltrials.gov/study/NCT03874715","title":"Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog® Versus Continuous Use of NovoLog in Participants With Type 1 Diabetes Mellitus Also Using Insulin Glargine","has_exemption":true,"start_date":"2019-03-11","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04030143","publication_url":"https://clinicaltrials.gov/study/NCT04030143","title":"A Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder","has_exemption":true,"start_date":"2019-08-01","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"reported-late","is_pact":false,"days_late":76},{"registry_id":"NCT04152083","publication_url":"https://clinicaltrials.gov/study/NCT04152083","title":"A Parallel Group, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing an Acute Attack of Migraine","has_exemption":false,"start_date":"2019-11-07","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04353271","publication_url":"https://clinicaltrials.gov/study/NCT04353271","title":"A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics","has_exemption":false,"start_date":"2020-04-17","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"University of South Alabama","sponsor_slug":"university-of-south-alabama","status":"reported-late","is_pact":false,"days_late":162},{"registry_id":"NCT04358068","publication_url":"https://clinicaltrials.gov/study/NCT04358068","title":"A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19","has_exemption":false,"start_date":"2020-05-13","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04189081","publication_url":"https://clinicaltrials.gov/study/NCT04189081","title":"A Clinical Study to Evaluate Dry Mouth Relief After Using an Experimental Mouth Rinse Compared to a Water Control","has_exemption":false,"start_date":"2020-05-13","completion_date":"2020-07-08","has_results":true,"results_due":true,"sponsor_name":"Procter and Gamble","sponsor_slug":"procter-and-gamble","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01772420","publication_url":"https://clinicaltrials.gov/study/NCT01772420","title":"Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2012-10-31","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"reported-late","is_pact":true,"days_late":682},{"registry_id":"NCT02140151","publication_url":"https://clinicaltrials.gov/study/NCT02140151","title":"Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (AMD) in Vulnerable Eyes With Nonexudative AMD Trial: A Multicenter, Prospectively Randomized, Masked and Controlled, Interventional Investigator Sponsored Phase I/II Study","has_exemption":false,"start_date":"2014-09-17","completion_date":"2020-07-09","has_results":false,"results_due":true,"sponsor_name":"Southern California Desert Retina Consultants, MC","sponsor_slug":"southern-california-desert-retina-consultants-mc","status":"reported-late","is_pact":true,"days_late":807},{"registry_id":"NCT03029247","publication_url":"https://clinicaltrials.gov/study/NCT03029247","title":"A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent","has_exemption":false,"start_date":"2017-07-27","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03197493","publication_url":"https://clinicaltrials.gov/study/NCT03197493","title":"Extension of Protocol 002, Carbidopa-levodopa in Neovascular Extension of Protocol 002, Carbidopa-levodopa in Neovascular AMD","has_exemption":false,"start_date":"2017-08-01","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"Snyder, Robert W., M.D., Ph.D., P.C.","sponsor_slug":"snyder-robert-w-md-phd-pc","status":"reported-late","is_pact":false,"days_late":1099},{"registry_id":"NCT03281837","publication_url":"https://clinicaltrials.gov/study/NCT03281837","title":"A Post-market, Single Blind, Multicenter, Randomized, Controlled Trial of HYMOVIS® Intra-articular Injections in Active Subjects With Knee Osteoarthritis","has_exemption":false,"start_date":"2017-10-01","completion_date":"2020-07-09","has_results":false,"results_due":true,"sponsor_name":"Fidia Pharma USA Inc.","sponsor_slug":"fidia-pharma-usa-inc","status":"overdue","is_pact":false,"days_late":1756},{"registry_id":"NCT03176784","publication_url":"https://clinicaltrials.gov/study/NCT03176784","title":"UW Quitting Using Intensive Treatment Study","has_exemption":false,"start_date":"2017-11-11","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03490760","publication_url":"https://clinicaltrials.gov/study/NCT03490760","title":"Phase II Trial of In Situ Tumor Vaccination Using Durvalumab and \"Booster\" Radiation Therapy in Patients With Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Through First-line Chemotherapy","has_exemption":false,"start_date":"2018-11-09","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"reported-late","is_pact":false,"days_late":774},{"registry_id":"NCT03877224","publication_url":"https://clinicaltrials.gov/study/NCT03877224","title":"International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction","has_exemption":false,"start_date":"2019-04-04","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03956862","publication_url":"https://clinicaltrials.gov/study/NCT03956862","title":"A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Effect of GB001 in Patients With Chronic Rhinosinusitis With or Without Nasal Polyps","has_exemption":false,"start_date":"2019-05-16","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.","sponsor_slug":"gb001-inc-a-wholly-owned-subsidiary-of-gossamer-bio-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04449341","publication_url":"https://clinicaltrials.gov/study/NCT04449341","title":"Can Virtual Reality Reduce Patient's Pain, Improve Patient's Experience, and Reduce Procedure Related Anxiety With Venipuncture? A Randomized Control Trial","has_exemption":false,"start_date":"2020-06-10","completion_date":"2020-07-09","has_results":true,"results_due":true,"sponsor_name":"C.R.Darnall Army Medical Center","sponsor_slug":"crdarnall-army-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01981850","publication_url":"https://clinicaltrials.gov/study/NCT01981850","title":"A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)","has_exemption":false,"start_date":"2013-10-01","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02732015","publication_url":"https://clinicaltrials.gov/study/NCT02732015","title":"Effects of Rolapitant on Nausea/Vomiting in Patients With Sarcoma Receiving Multi-Day Highly Emetogenic Chemotherapy (HEC) With Doxorubicin and Ifosfamide Regimen (AI)","has_exemption":false,"start_date":"2016-10-12","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02784288","publication_url":"https://clinicaltrials.gov/study/NCT02784288","title":"Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer","has_exemption":true,"start_date":"2016-10-31","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03305809","publication_url":"https://clinicaltrials.gov/study/NCT03305809","title":"Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)","has_exemption":false,"start_date":"2017-11-09","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03252522","publication_url":"https://clinicaltrials.gov/study/NCT03252522","title":"Evaluating the Efficacy of Supplementation With Micronutrients for ADHD in Youth (MADDY) Study","has_exemption":true,"start_date":"2018-04-23","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03669042","publication_url":"https://clinicaltrials.gov/study/NCT03669042","title":"Post-market, Prospective Evaluation of PHOTO-oxidized Decellularized Bovine Pericardium Used as a Patch in Vascular Repair and Reconstruction Surgery","has_exemption":false,"start_date":"2018-11-20","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"Artivion Inc.","sponsor_slug":"artivion-inc","status":"reported-late","is_pact":false,"days_late":1138},{"registry_id":"NCT04196140","publication_url":"https://clinicaltrials.gov/study/NCT04196140","title":"Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes","has_exemption":false,"start_date":"2019-12-30","completion_date":"2020-07-10","has_results":true,"results_due":true,"sponsor_name":"Insulet Corporation","sponsor_slug":"insulet-corporation","status":"reported-late","is_pact":false,"days_late":843},{"registry_id":"NCT00695786","publication_url":"https://clinicaltrials.gov/study/NCT00695786","title":"A Phase II Study of Revlimid in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Hodgkin's Lymphoma (NHL)","has_exemption":false,"start_date":"2008-06-10","completion_date":"2020-07-11","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02343549","publication_url":"https://clinicaltrials.gov/study/NCT02343549","title":"A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)","has_exemption":false,"start_date":"2015-01-31","completion_date":"2020-07-11","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":true,"days_late":6},{"registry_id":"NCT06473662","publication_url":"https://clinicaltrials.gov/study/NCT06473662","title":"A Phase 2b, Open-label Randomized Comparative Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects Uncontrolled With Metformin Hydrochloride Treatment","has_exemption":false,"start_date":"2018-10-22","completion_date":"2020-07-11","has_results":true,"results_due":true,"sponsor_name":"Roger New","sponsor_slug":"roger-new","status":"reported-late","is_pact":false,"days_late":1177},{"registry_id":"NCT04353037","publication_url":"https://clinicaltrials.gov/study/NCT04353037","title":"PATCH 2 & 3: (Prevention and Treatment of COVID-19 With Hydroxychloroquine) A Double-blind Placebo Controlled Randomized Trial of Hydroxychloroquine in the Prevention and Treatment of COVID-19","has_exemption":false,"start_date":"2020-04-07","completion_date":"2020-07-11","has_results":true,"results_due":true,"sponsor_name":"UnitedHealth Group","sponsor_slug":"unitedhealth-group","status":"reported-late","is_pact":false,"days_late":11},{"registry_id":"NCT03179943","publication_url":"https://clinicaltrials.gov/study/NCT03179943","title":"GU-114: Overcoming Checkpoint Inhibitor Resistance With Epigenetic Therapy in Urothelial Cancer","has_exemption":false,"start_date":"2017-11-27","completion_date":"2020-07-12","has_results":false,"results_due":true,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"reported-late","is_pact":false,"days_late":303},{"registry_id":"NCT03694275","publication_url":"https://clinicaltrials.gov/study/NCT03694275","title":"A Multicenter, Open-label, Pilot Study of TAK-935 (OV935) in Patients With 15Q Duplication Syndrome or CDKL5 Deficiency Disorder (ARCADE Study)","has_exemption":false,"start_date":"2018-09-10","completion_date":"2020-07-13","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03987074","publication_url":"https://clinicaltrials.gov/study/NCT03987074","title":"A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)","has_exemption":false,"start_date":"2019-07-29","completion_date":"2020-07-13","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04328467","publication_url":"https://clinicaltrials.gov/study/NCT04328467","title":"Pre-exposure Prophylaxis for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial","has_exemption":false,"start_date":"2020-04-06","completion_date":"2020-07-13","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04356937","publication_url":"https://clinicaltrials.gov/study/NCT04356937","title":"Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized Non-Critically Ill Patients With COVID-19","has_exemption":false,"start_date":"2020-04-20","completion_date":"2020-07-13","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04415073","publication_url":"https://clinicaltrials.gov/study/NCT04415073","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Axatilimab for the Treatment of Hospitalized Patients With Respiratory Signs and Symptoms Secondary to Novel Coronavirus Disease (COVID-19)","has_exemption":false,"start_date":"2020-05-30","completion_date":"2020-07-13","has_results":true,"results_due":true,"sponsor_name":"Syndax Pharmaceuticals","sponsor_slug":"syndax-pharmaceuticals","status":"reported-late","is_pact":false,"days_late":351},{"registry_id":"NCT02362035","publication_url":"https://clinicaltrials.gov/study/NCT02362035","title":"A Phase 1b/2 Proof-of-Concept Study of the Combination of ACP-196 (Acalabrutinib) and Pembrolizumab in Subjects With Hematologic Malignancies","has_exemption":false,"start_date":"2015-02-20","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02338999","publication_url":"https://clinicaltrials.gov/study/NCT02338999","title":"The Role of PPAR-Gamma Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)","has_exemption":false,"start_date":"2015-06-18","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","sponsor_slug":"national-institute-of-arthritis-and-musculoskeletal-and-skin-diseases-niams","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02949362","publication_url":"https://clinicaltrials.gov/study/NCT02949362","title":"A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003","has_exemption":false,"start_date":"2016-12-09","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Shire","sponsor_slug":"shire","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03126760","publication_url":"https://clinicaltrials.gov/study/NCT03126760","title":"A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of Acthar® in Subjects With Relapsing-remitting Multiple Sclerosis","has_exemption":false,"start_date":"2017-05-22","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Mallinckrodt ARD LLC","sponsor_slug":"mallinckrodt-ard-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03595618","publication_url":"https://clinicaltrials.gov/study/NCT03595618","title":"Efficacy and Safety of 3 Doses of S201086/GLPG1972 Administered Orally Once Daily in Patients With Knee Osteoarthritis. A 52-week International, Multi-regional, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study","has_exemption":false,"start_date":"2018-08-14","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Galapagos NV","sponsor_slug":"galapagos-nv","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03632967","publication_url":"https://clinicaltrials.gov/study/NCT03632967","title":"Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System","has_exemption":false,"start_date":"2018-09-12","completion_date":"2020-07-14","has_results":false,"results_due":true,"sponsor_name":"4Tech Cardio Ltd.","sponsor_slug":"4tech-cardio-ltd","status":"overdue","is_pact":false,"days_late":1751},{"registry_id":"NCT03656692","publication_url":"https://clinicaltrials.gov/study/NCT03656692","title":"A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of Acthar Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU)","has_exemption":false,"start_date":"2018-10-05","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Mallinckrodt","sponsor_slug":"mallinckrodt","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03712280","publication_url":"https://clinicaltrials.gov/study/NCT03712280","title":"A Randomized, Open-Label, Phase 2a Comparator Study to Assess the Pharmacodynamics, Safety and Pharmacokinetics of Oral Administration MNK6106 (L-Ornithine Phenylacetate) Versus Rifaximin in Subjects With Hepatic Cirrhosis and a History of Prior Episodes of Hepatic Encephalopathy","has_exemption":false,"start_date":"2018-12-01","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"Mallinckrodt","sponsor_slug":"mallinckrodt","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03766685","publication_url":"https://clinicaltrials.gov/study/NCT03766685","title":"A Multicenter, Randomized, Open-Label Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-Injector for the Subcutaneous Self-Injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis","has_exemption":true,"start_date":"2018-12-20","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03931408","publication_url":"https://clinicaltrials.gov/study/NCT03931408","title":"The Evaluation of Antimicrobial Bladder Instillation on the Prevalence of Chronic Urinary Tract Infections and Bladder Dysfunction in Persons With Spinal Cord Injury","has_exemption":false,"start_date":"2019-02-19","completion_date":"2020-07-14","has_results":true,"results_due":true,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"reported-late","is_pact":false,"days_late":1021},{"registry_id":"NCT03960606","publication_url":"https://clinicaltrials.gov/study/NCT03960606","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, & Pharmacokinetics of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) in Asthmatic Patients With ABPA","has_exemption":true,"start_date":"2019-07-31","completion_date":"2020-07-14","has_results":false,"results_due":true,"sponsor_name":"Pulmatrix Inc.","sponsor_slug":"pulmatrix-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02006147","publication_url":"https://clinicaltrials.gov/study/NCT02006147","title":"Phase I/II Trial of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)","has_exemption":false,"start_date":"2014-11-30","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Taiwan Liposome Company","sponsor_slug":"taiwan-liposome-company","status":"reported-late","is_pact":true,"days_late":132},{"registry_id":"NCT02255656","publication_url":"https://clinicaltrials.gov/study/NCT02255656","title":"A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)","has_exemption":false,"start_date":"2015-01-07","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02334735","publication_url":"https://clinicaltrials.gov/study/NCT02334735","title":"Poly-ICLC Matured DC as an Adjuvant for NY-ESO-1 and Melan-A/MART-1 Peptide Vaccination Compared to Montanide® ISA-51 VG, in Study Subjects With Melanoma in Complete Clinical Remission But at High Risk of Disease Recurrence","has_exemption":false,"start_date":"2015-07-01","completion_date":"2020-07-15","has_results":false,"results_due":true,"sponsor_name":"Nina Bhardwaj","sponsor_slug":"nina-bhardwaj","status":"reported-late","is_pact":true,"days_late":777},{"registry_id":"NCT02400281","publication_url":"https://clinicaltrials.gov/study/NCT02400281","title":"Phase I-II Study of Crenolanib Combined With Standard Salvage Chemotherapy, and Crenolanib Combined With 5-Azacitidine in Acute Myeloid Leukemia Patients With FLT3 Activating Mutations","has_exemption":false,"start_date":"2015-09-30","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"reported-late","is_pact":true,"days_late":860},{"registry_id":"NCT02346201","publication_url":"https://clinicaltrials.gov/study/NCT02346201","title":"Apathy in Dementia Methylphenidate Trial 2","has_exemption":false,"start_date":"2016-01-31","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins Bloomberg School of Public Health","sponsor_slug":"johns-hopkins-bloomberg-school-of-public-health","status":"reported-late","is_pact":true,"days_late":648},{"registry_id":"NCT03259308","publication_url":"https://clinicaltrials.gov/study/NCT03259308","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)","has_exemption":false,"start_date":"2017-12-05","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Shire","sponsor_slug":"shire","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03448887","publication_url":"https://clinicaltrials.gov/study/NCT03448887","title":"Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial","has_exemption":false,"start_date":"2018-03-15","completion_date":"2020-07-15","has_results":false,"results_due":true,"sponsor_name":"Seoul National University Hospital","sponsor_slug":"seoul-national-university-hospital","status":"overdue","is_pact":false,"days_late":1750},{"registry_id":"NCT03545165","publication_url":"https://clinicaltrials.gov/study/NCT03545165","title":"Phase I/II Dose-Escalation Trial of Combination Fractionated-dose 177Lu-J591 and 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2018-04-18","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03474107","publication_url":"https://clinicaltrials.gov/study/NCT03474107","title":"An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)","has_exemption":false,"start_date":"2018-06-27","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03710889","publication_url":"https://clinicaltrials.gov/study/NCT03710889","title":"An Open-Label, Single-Arm, Multicenter Study to Evaluate the Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption","has_exemption":false,"start_date":"2018-09-20","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Radius Health, Inc.","sponsor_slug":"radius-health-inc","status":"reported-late","is_pact":false,"days_late":52},{"registry_id":"NCT03517566","publication_url":"https://clinicaltrials.gov/study/NCT03517566","title":"A Randomized, Double-blind, Placebo-controlled Multicenter Dose Ranging Study to Assess the Safety and Efficacy of Multiple Oral ZPL389 Doses in Patients With Moderate to Severe Atopic Dermatitis (ZEST Trial)","has_exemption":false,"start_date":"2018-11-14","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03784963","publication_url":"https://clinicaltrials.gov/study/NCT03784963","title":"Open-Label Prospective Randomized Control Trial to Investigate the Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device","has_exemption":false,"start_date":"2019-01-23","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02889393","publication_url":"https://clinicaltrials.gov/study/NCT02889393","title":"Teduglutide for Treatment of Enterocutaneous Fistula (ECF) - a Pilot Study to Demonstrate Safety and Feasibility","has_exemption":false,"start_date":"2019-01-31","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Daniel Dante Yeh","sponsor_slug":"daniel-dante-yeh","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03792555","publication_url":"https://clinicaltrials.gov/study/NCT03792555","title":"A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients With Acromegaly That Are Responders to Octreotide LAR or Lanreotide Depot (ACROBAT Evolve)","has_exemption":true,"start_date":"2019-03-11","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":424},{"registry_id":"NCT03797144","publication_url":"https://clinicaltrials.gov/study/NCT03797144","title":"A Prospective, Multicenter Evaluation of the CD HORIZON® Fenestrated Screw Spinal System With Fenestrated Screw Cement When Used in the Treatment of Spinal Conditions in Subjects With Compromised Bone Quality","has_exemption":false,"start_date":"2019-04-18","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Medtronic Spinal and Biologics","sponsor_slug":"medtronic-spinal-and-biologics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03982368","publication_url":"https://clinicaltrials.gov/study/NCT03982368","title":"A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.","has_exemption":false,"start_date":"2019-06-10","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"reported-late","is_pact":false,"days_late":70},{"registry_id":"NCT02699086","publication_url":"https://clinicaltrials.gov/study/NCT02699086","title":"A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part I","has_exemption":false,"start_date":"2019-12-01","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"BioLite, Inc.","sponsor_slug":"biolite-inc","status":"reported-late","is_pact":false,"days_late":34},{"registry_id":"NCT04103164","publication_url":"https://clinicaltrials.gov/study/NCT04103164","title":"Open Label, Prospective, Single-Center Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser.","has_exemption":false,"start_date":"2020-01-15","completion_date":"2020-07-15","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":1750},{"registry_id":"NCT04380090","publication_url":"https://clinicaltrials.gov/study/NCT04380090","title":"Efficacy of One Dose of Laxative on Post-Operative Constipation Following Total Knee Arthroplasty","has_exemption":false,"start_date":"2020-02-21","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"reported-late","is_pact":false,"days_late":74},{"registry_id":"NCT04435808","publication_url":"https://clinicaltrials.gov/study/NCT04435808","title":"Off Label Study to Evaluate the Efficacy of Hydroxychloroquine as Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Health Care Workers at High Risk of Occupational Exposure to SARS-CoV-2","has_exemption":false,"start_date":"2020-04-14","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04341675","publication_url":"https://clinicaltrials.gov/study/NCT04341675","title":"Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial)","has_exemption":false,"start_date":"2020-04-24","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"reported-late","is_pact":false,"days_late":967},{"registry_id":"NCT04015336","publication_url":"https://clinicaltrials.gov/study/NCT04015336","title":"A Phase II Study of E7 TCR T Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer","has_exemption":false,"start_date":"2020-07-06","completion_date":"2020-07-15","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":false,"days_late":146},{"registry_id":"NCT01379573","publication_url":"https://clinicaltrials.gov/study/NCT01379573","title":"Preventive Approach to Congenital Heart Block With Hydroxychloroquine","has_exemption":false,"start_date":"2011-01-01","completion_date":"2020-07-16","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02962102","publication_url":"https://clinicaltrials.gov/study/NCT02962102","title":"Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury (ACTIVATE-AKI)","has_exemption":false,"start_date":"2017-04-03","completion_date":"2020-07-16","has_results":true,"results_due":true,"sponsor_name":"David Leaf","sponsor_slug":"david-leaf","status":"reported-late","is_pact":false,"days_late":144},{"registry_id":"NCT03426345","publication_url":"https://clinicaltrials.gov/study/NCT03426345","title":"A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis","has_exemption":false,"start_date":"2018-02-16","completion_date":"2020-07-16","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06119750","publication_url":"https://clinicaltrials.gov/study/NCT06119750","title":"4-Day Primary Irritation Patch Test of MIS Solution","has_exemption":false,"start_date":"2020-07-06","completion_date":"2020-07-16","has_results":false,"results_due":true,"sponsor_name":"Next Science TM","sponsor_slug":"next-science-tm","status":"overdue","is_pact":false,"days_late":1749},{"registry_id":"NCT03000010","publication_url":"https://clinicaltrials.gov/study/NCT03000010","title":"Incisional Vacuum-assisted Closure Therapy After Posterior Spinal Fusion for Pediatric Neuromuscular Scoliosis","has_exemption":false,"start_date":"2012-07-16","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02393690","publication_url":"https://clinicaltrials.gov/study/NCT02393690","title":"Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in Combination With Placebo or Selumetinib for the Treatment of RAI-Avid Recurrent/Metastatic Thyroid Cancers","has_exemption":false,"start_date":"2015-05-04","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Academic and Community Cancer Research United","sponsor_slug":"academic-and-community-cancer-research-united","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02632409","publication_url":"https://clinicaltrials.gov/study/NCT02632409","title":"A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subjects With High Risk Invasive Urothelial Carcinoma (CheckMate 274: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 274)","has_exemption":false,"start_date":"2016-03-22","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02979587","publication_url":"https://clinicaltrials.gov/study/NCT02979587","title":"The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study","has_exemption":false,"start_date":"2017-01-31","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Medtronic Heart Valves","sponsor_slug":"medtronic-heart-valves","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03004976","publication_url":"https://clinicaltrials.gov/study/NCT03004976","title":"Phase 2 Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke - CoBIS 2","has_exemption":true,"start_date":"2017-03-14","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Joanne Kurtzberg, MD","sponsor_slug":"joanne-kurtzberg-md","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03077698","publication_url":"https://clinicaltrials.gov/study/NCT03077698","title":"A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma","has_exemption":false,"start_date":"2017-06-14","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Xenetic Biosciences, Inc.","sponsor_slug":"xenetic-biosciences-inc","status":"reported-late","is_pact":false,"days_late":235},{"registry_id":"NCT03190473","publication_url":"https://clinicaltrials.gov/study/NCT03190473","title":"The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study","has_exemption":false,"start_date":"2018-01-02","completion_date":"2020-07-17","has_results":false,"results_due":true,"sponsor_name":"Svelte Medical Systems, Inc.","sponsor_slug":"svelte-medical-systems-inc","status":"overdue","is_pact":false,"days_late":1748},{"registry_id":"NCT03511560","publication_url":"https://clinicaltrials.gov/study/NCT03511560","title":"To Understand the Impact of Immunosuppression Using Once-per-day Envarsus XR on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation","has_exemption":false,"start_date":"2018-07-26","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported-late","is_pact":false,"days_late":47},{"registry_id":"NCT03728309","publication_url":"https://clinicaltrials.gov/study/NCT03728309","title":"Protocol Title: A Randomized, Multicenter, Evaluator-blind, Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM VOLITE™ XC Injectable Gel for the Improvement in Cheek Skin Smoothness","has_exemption":true,"start_date":"2018-11-09","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04222725","publication_url":"https://clinicaltrials.gov/study/NCT04222725","title":"A Multicenter, Double-Masked, Randomized, Vehicle-controlled, Dose-ranging Study to Evaluate the Safety of TRS01 Eye Drops in Participants With Post-surgical Inflammation","has_exemption":false,"start_date":"2020-02-01","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Tarsier Pharma","sponsor_slug":"tarsier-pharma","status":"reported-late","is_pact":false,"days_late":55},{"registry_id":"NCT04378114","publication_url":"https://clinicaltrials.gov/study/NCT04378114","title":"Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults","has_exemption":true,"start_date":"2020-05-18","completion_date":"2020-07-17","has_results":true,"results_due":true,"sponsor_name":"Medtronic MiniMed, Inc.","sponsor_slug":"medtronic-minimed-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00960752","publication_url":"https://clinicaltrials.gov/study/NCT00960752","title":"Activation of pDCs at the Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist","has_exemption":false,"start_date":"2010-05-20","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02292238","publication_url":"https://clinicaltrials.gov/study/NCT02292238","title":"Benfotiamine in Alzheimer's Disease: A Pilot Study","has_exemption":false,"start_date":"2015-02-15","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Burke Medical Research Institute","sponsor_slug":"burke-medical-research-institute","status":"reported-late","is_pact":true,"days_late":231},{"registry_id":"NCT03046056","publication_url":"https://clinicaltrials.gov/study/NCT03046056","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)","has_exemption":false,"start_date":"2017-04-11","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03305666","publication_url":"https://clinicaltrials.gov/study/NCT03305666","title":"A Randomized Clinical Trial of Single Dose Liposomal Bupivacaine Delivered Via VATS Intercostal Nerve Block vs. Continuous Bupivacaine Infusion Delivered Via Indwelling Subscapular Catheter After Surgical Stabilization of Rib Fractures","has_exemption":false,"start_date":"2017-10-05","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Denver Health and Hospital Authority","sponsor_slug":"denver-health-and-hospital-authority","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03394885","publication_url":"https://clinicaltrials.gov/study/NCT03394885","title":"Atezolizumab in Combination With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients With Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer","has_exemption":false,"start_date":"2018-06-19","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06416735","publication_url":"https://clinicaltrials.gov/study/NCT06416735","title":"Natriruetic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant","has_exemption":false,"start_date":"2018-09-28","completion_date":"2020-07-20","has_results":false,"results_due":true,"sponsor_name":"Ospedale San Raffaele","sponsor_slug":"ospedale-san-raffaele","status":"overdue","is_pact":false,"days_late":1745},{"registry_id":"NCT03713957","publication_url":"https://clinicaltrials.gov/study/NCT03713957","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment","has_exemption":false,"start_date":"2018-11-12","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Alkahest, Inc.","sponsor_slug":"alkahest-inc","status":"reported-late","is_pact":false,"days_late":141},{"registry_id":"NCT03872336","publication_url":"https://clinicaltrials.gov/study/NCT03872336","title":"Acute Labetalol Use in Preeclampsia Randomized Trial","has_exemption":false,"start_date":"2019-02-18","completion_date":"2020-07-20","has_results":false,"results_due":true,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"overdue","is_pact":false,"days_late":1745},{"registry_id":"NCT03877692","publication_url":"https://clinicaltrials.gov/study/NCT03877692","title":"Acute Control of Chronic Hypertension in Preeclampsia","has_exemption":false,"start_date":"2019-02-18","completion_date":"2020-07-20","has_results":false,"results_due":true,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"overdue","is_pact":false,"days_late":1745},{"registry_id":"NCT04083222","publication_url":"https://clinicaltrials.gov/study/NCT04083222","title":"A Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously for 8 Weeks to Hypertensive Subjects With Uncontrolled Blood Pressure","has_exemption":false,"start_date":"2019-11-13","completion_date":"2020-07-20","has_results":true,"results_due":true,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":519},{"registry_id":"NCT04468139","publication_url":"https://clinicaltrials.gov/study/NCT04468139","title":"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19","has_exemption":false,"start_date":"2020-06-20","completion_date":"2020-07-20","has_results":false,"results_due":true,"sponsor_name":"Ministry of Health, Saudi Arabia","sponsor_slug":"ministry-of-health-saudi-arabia","status":"overdue","is_pact":false,"days_late":1745},{"registry_id":"NCT00950846","publication_url":"https://clinicaltrials.gov/study/NCT00950846","title":"Umbilical Cord Blood Transplant for Congenital Pediatric Disorders","has_exemption":false,"start_date":"2009-09-30","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"reported-late","is_pact":true,"days_late":716},{"registry_id":"NCT02002819","publication_url":"https://clinicaltrials.gov/study/NCT02002819","title":"Phase 2a Levetiracetam Trial for AD-Associated Network Hyperexcitability","has_exemption":false,"start_date":"2014-10-16","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":true,"days_late":75},{"registry_id":"NCT02404441","publication_url":"https://clinicaltrials.gov/study/NCT02404441","title":"Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients With Advanced Malignancies","has_exemption":false,"start_date":"2015-04-27","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03237858","publication_url":"https://clinicaltrials.gov/study/NCT03237858","title":"Multiple Cardiac Sensors for the Management of Heart Failure","has_exemption":false,"start_date":"2017-08-30","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported-late","is_pact":false,"days_late":853},{"registry_id":"NCT03320850","publication_url":"https://clinicaltrials.gov/study/NCT03320850","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence","has_exemption":false,"start_date":"2017-10-04","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03549312","publication_url":"https://clinicaltrials.gov/study/NCT03549312","title":"Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Switch Followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy Followed by Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Simplification in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy - A Pilot Feasibility Study","has_exemption":false,"start_date":"2018-02-01","completion_date":"2020-07-21","has_results":false,"results_due":true,"sponsor_name":"Saskatchewan Health Authority - Regina Area","sponsor_slug":"saskatchewan-health-authority-regina-area","status":"overdue","is_pact":false,"days_late":1744},{"registry_id":"NCT04343651","publication_url":"https://clinicaltrials.gov/study/NCT04343651","title":"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)","has_exemption":false,"start_date":"2020-04-01","completion_date":"2020-07-21","has_results":true,"results_due":true,"sponsor_name":"CytoDyn, Inc.","sponsor_slug":"cytodyn-inc","status":"reported-late","is_pact":false,"days_late":372},{"registry_id":"NCT00759798","publication_url":"https://clinicaltrials.gov/study/NCT00759798","title":"Prospective Identification of Significant Prognostic Factors in Patients Treated With Fludarabine, Cyclophosphamide, and Rituximab (FCR) as Initial Therapy for Chronic Lymphocytic Leukemia.","has_exemption":false,"start_date":"2008-08-13","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported-late","is_pact":true,"days_late":20},{"registry_id":"NCT02092467","publication_url":"https://clinicaltrials.gov/study/NCT02092467","title":"PHASE 3B/4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR (TNF) INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS","has_exemption":false,"start_date":"2014-03-14","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02304302","publication_url":"https://clinicaltrials.gov/study/NCT02304302","title":"Phase II Multicenter 16-Week Randomized Double Blind Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults With Down Syndrome","has_exemption":false,"start_date":"2014-10-31","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"reported-late","is_pact":true,"days_late":153},{"registry_id":"NCT02635386","publication_url":"https://clinicaltrials.gov/study/NCT02635386","title":"Comparison of Dapagliflozin (DAPA) and Once-weekly Exenatide (EQW), Co-administered or Alone, DAPA/ Glucophage (DAPA/MET ER) and Phentermine/Topiramate (PHEN/TPM) ER on Metabolic Profiles and Body Composition in Obese PCOS Women","has_exemption":false,"start_date":"2016-03-22","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Woman's","sponsor_slug":"womans","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03111732","publication_url":"https://clinicaltrials.gov/study/NCT03111732","title":"A Phase 2 Study of Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in Subjects With Advanced Biliary Tract Carcinoma (BTC)","has_exemption":false,"start_date":"2017-06-14","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03285178","publication_url":"https://clinicaltrials.gov/study/NCT03285178","title":"A Randomized, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Pharmacodynamics of Once-daily Oral IW-1701 in Patients With Stable Sickle Cell Disease","has_exemption":true,"start_date":"2017-12-22","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Cyclerion Therapeutics","sponsor_slug":"cyclerion-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03259334","publication_url":"https://clinicaltrials.gov/study/NCT03259334","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)","has_exemption":false,"start_date":"2018-02-09","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Shire","sponsor_slug":"shire","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03411902","publication_url":"https://clinicaltrials.gov/study/NCT03411902","title":"Effect of Bisphosphonate Use on Surgical Weight Loss Associated Bone Loss in Older Adults With Morbid Obesity","has_exemption":false,"start_date":"2018-06-15","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03706521","publication_url":"https://clinicaltrials.gov/study/NCT03706521","title":"A Phase 2, 52 Week, Single Center, Open-Label Study Utilizing Imaging Techniques and Evaluating the Safety and Efficacy of SM04690 Injectable Suspension for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis","has_exemption":true,"start_date":"2019-03-11","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Biosplice Therapeutics, Inc.","sponsor_slug":"biosplice-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":873},{"registry_id":"NCT03922711","publication_url":"https://clinicaltrials.gov/study/NCT03922711","title":"A Double-Blind, Randomized, Three-Arm, Parallel-Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)","has_exemption":false,"start_date":"2019-05-22","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Prilenia","sponsor_slug":"prilenia","status":"reported-late","is_pact":false,"days_late":271},{"registry_id":"NCT03942042","publication_url":"https://clinicaltrials.gov/study/NCT03942042","title":"A Multicenter, Open-Label, Post Marketing Clinical Trial to Evaluate the Efficacy And Safety Of Ixekizumab in Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis","has_exemption":false,"start_date":"2019-07-05","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03714555","publication_url":"https://clinicaltrials.gov/study/NCT03714555","title":"A Phase II Pilot Study of Disulfiram and Copper Gluconate in Patients With Metastatic Pancreatic Cancer and Rising CA-19-9 Levels While Receiving Abraxane-Gemcitabine or FOLFIRINOX or Single-Agent Gemcitabine","has_exemption":false,"start_date":"2019-10-17","completion_date":"2020-07-22","has_results":true,"results_due":true,"sponsor_name":"HonorHealth Research Institute","sponsor_slug":"honorhealth-research-institute","status":"reported-late","is_pact":false,"days_late":763},{"registry_id":"NCT02740114","publication_url":"https://clinicaltrials.gov/study/NCT02740114","title":"Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway: A Single-Blinded, Randomized, Controlled Study","has_exemption":false,"start_date":"2016-08-31","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03180684","publication_url":"https://clinicaltrials.gov/study/NCT03180684","title":"A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva","has_exemption":true,"start_date":"2017-08-31","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Inovio Pharmaceuticals","sponsor_slug":"inovio-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03277261","publication_url":"https://clinicaltrials.gov/study/NCT03277261","title":"Phase III: UbLiTuximab In Multiple Sclerosis Treatment Effects (ULTIMATE I STUDY)","has_exemption":true,"start_date":"2017-09-19","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"TG Therapeutics, Inc.","sponsor_slug":"tg-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03505021","publication_url":"https://clinicaltrials.gov/study/NCT03505021","title":"Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS","has_exemption":false,"start_date":"2018-06-21","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Orion Corporation, Orion Pharma","sponsor_slug":"orion-corporation-orion-pharma","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03597035","publication_url":"https://clinicaltrials.gov/study/NCT03597035","title":"Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On","has_exemption":false,"start_date":"2018-07-17","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"reported-late","is_pact":false,"days_late":88},{"registry_id":"NCT03844074","publication_url":"https://clinicaltrials.gov/study/NCT03844074","title":"A Clinical Effectiveness, Multicenter, Randomized, Double-masked, Controlled Study of the Efficacy and Safety of ONS-5010 in Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration","has_exemption":true,"start_date":"2018-10-01","completion_date":"2020-07-23","has_results":false,"results_due":true,"sponsor_name":"Outlook Therapeutics, Inc.","sponsor_slug":"outlook-therapeutics-inc","status":"overdue","is_pact":false,"days_late":1012},{"registry_id":"NCT03683576","publication_url":"https://clinicaltrials.gov/study/NCT03683576","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multi-center Study to Evaluate the Efficacy and Safety of GB001 as Maintenance Therapy in Adult Subjects With Moderate to Severe Asthma","has_exemption":false,"start_date":"2018-10-22","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.","sponsor_slug":"gb001-inc-a-wholly-owned-subsidiary-of-gossamer-bio-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03781479","publication_url":"https://clinicaltrials.gov/study/NCT03781479","title":"A Randomized, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Amifampridine Phosphate in Ambulatory Patients With Spinal Muscular Atrophy (SMA) Type 3","has_exemption":false,"start_date":"2019-01-21","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Catalyst Pharmaceuticals, Inc.","sponsor_slug":"catalyst-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03847922","publication_url":"https://clinicaltrials.gov/study/NCT03847922","title":"Nitrous Oxide for Analgesia During Office Urethral Bulking: a Randomized, Controlled Trial","has_exemption":false,"start_date":"2019-02-15","completion_date":"2020-07-23","has_results":false,"results_due":true,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"overdue","is_pact":false,"days_late":1742},{"registry_id":"NCT03948334","publication_url":"https://clinicaltrials.gov/study/NCT03948334","title":"A Randomized, Double Blind, Multicenter Extension to CZPL389A2203 Dose-ranging Study to Assess the Short-term and Long-term Safety and Efficacy of Oral ZPL389 With Concomitant Use of TCS and/or TCI in Adult Patients With Atopic Dermatitis.","has_exemption":false,"start_date":"2019-04-04","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04707547","publication_url":"https://clinicaltrials.gov/study/NCT04707547","title":"Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy","has_exemption":false,"start_date":"2019-10-16","completion_date":"2020-07-23","has_results":false,"results_due":true,"sponsor_name":"Taipei Medical University WanFang Hospital","sponsor_slug":"taipei-medical-university-wanfang-hospital","status":"overdue","is_pact":false,"days_late":1742},{"registry_id":"NCT04126213","publication_url":"https://clinicaltrials.gov/study/NCT04126213","title":"A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers","has_exemption":true,"start_date":"2019-11-05","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04209530","publication_url":"https://clinicaltrials.gov/study/NCT04209530","title":"A Phase 2a, Open Label Study to Assess the Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Females Using Photonumeric Scales, Magnetic Resonance Imaging and Histopathology","has_exemption":false,"start_date":"2019-11-20","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Endo Pharmaceuticals","sponsor_slug":"endo-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04343261","publication_url":"https://clinicaltrials.gov/study/NCT04343261","title":"Convalescent Plasma in the Treatment of COVID 19","has_exemption":false,"start_date":"2020-04-10","completion_date":"2020-07-23","has_results":true,"results_due":true,"sponsor_name":"Trinity Health Of New England","sponsor_slug":"trinity-health-of-new-england","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02693262","publication_url":"https://clinicaltrials.gov/study/NCT02693262","title":"Rate Response With CLS Versus Accelerometer and Effect on Both Subjective Symptoms and Objective Outcomes in a Heart Failure Population Implanted With Cardiac Resynchronization With Defibrillator Device: The CLASS Trial","has_exemption":false,"start_date":"2016-07-31","completion_date":"2020-07-24","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported","is_pact":true,"days_late":null}]}